These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 463670)

  • 21. Toxicological studies with therapeutically-applicable Vibrio cholerae neuraminidase.
    Ronneberger H
    Dev Biol Stand; 1977 Apr 13-15; 38():413-9. PubMed ID: 608531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Problems of cancer immunotherapy (author's transl)].
    Gericke D
    MMW Munch Med Wochenschr; 1977 Nov; 119(46):1497-1500. PubMed ID: 414081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapy in an intracerebral murine glioma model, using Bacillus Calmette-Guérin, neuraminidase-treated tumor cells, and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Albright L; Madigan JC; Gaston MR; Houchens DP
    Cancer Res; 1975 Mar; 35(3):658-65. PubMed ID: 234790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experimental study on active specific immunotherapy utilizing the immune reaction of low-dose irradiated tumor tissue. 8. Effect of mitomycin C-treated active specific immunotherapy].
    Imanaka K; Gose K; Ichiyanagi A; Ashida C; Hamada F; Hashimura T; Takimoto S; Murakami M; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1983 Jun; 18(4):940-5. PubMed ID: 6413626
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experiments on the treatment of Yoshida tumor with neuroaminidase of Vibrio cholerae].
    Sánchez Cousteau JA; Justo Alpañes E; Ledro Molina D; Ferreiro Madueño M; Gomez Parra M; Ramírez Martínez R; Valle Bernal MJ; Astolfi Pérez de Guzmán J; Garrido Peralta M
    Rev Clin Esp; 1979 Sep; 154(5):183-6. PubMed ID: 523718
    [No Abstract]   [Full Text] [Related]  

  • 26. [Inhibiting effect of cholera vibrio neuraminidase in Rauscher mouse leukemia].
    Barinskiĭ IF; Korbinskiĭ GD
    Biull Eksp Biol Med; 1976; 82(11):1357-9. PubMed ID: 1016719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation therapy and immunotherapy: the value of immunotherapy in the control of local and regional cancer.
    Cancer; 1976 Apr; 37(4 Suppl):2108-19. PubMed ID: 769945
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of neuraminidase-treated and mitomycin C-treated polyoma tumour cells on the established tumour growth in CBA mice. I. An attempt at evaluation of polyoma tumour destruction using the distribution of lissamine green method.
    Porwit-Bóbr Z; Slowik M; Tomecki J
    Folia Histochem Cytochem (Krakow); 1974; 12(3-4):315-20. PubMed ID: 4141984
    [No Abstract]   [Full Text] [Related]  

  • 29. The immunotherapy of advanced human cancer with neuraminidase.
    Ngu VA; Osunkoya BO; Ajayi OO; Khwaja MS
    Niger Med J; 1973 Jan; 3(1):15-9. PubMed ID: 4805217
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of the enzyme neuraminidase for immunotherapeutic treatment of chemically induced carcinogenesis].
    Maĭskiĭ IN; Aĭrapet'ian GP; Kobrinskiĭ GD; Troitskaia NA; Gudkova GB
    Biull Eksp Biol Med; 1977 Dec; 84(12):714-7. PubMed ID: 413595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relevance of virus-induced immunodepression to oncogenesis.
    Bendinelli M
    G Batteriol Virol Immunol; 1974; 67(7-12):173-9. PubMed ID: 4478766
    [No Abstract]   [Full Text] [Related]  

  • 32. Enhanced cures of spontaneous murine mammary carcinomas with surgery and five-compound combination chemotherapy, and their immunotherapeutic interrelationship.
    Fugmann RA; Martin DS; Hayworth PE; Stolfi RL
    Cancer Res; 1970 Jul; 30(7):1931-6. PubMed ID: 5456078
    [No Abstract]   [Full Text] [Related]  

  • 33. [Transplantability and immunogenicity in mice of lymphoma Nk/Ly cells modified by concanavalin A and neuraminidase].
    Bratus' GG; Darchuk GF
    Eksp Onkol; 1989; 11(3):35-8. PubMed ID: 2752940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological studies in murine osteosarcoma. Immunogenicity, growth kinetics, and immunotherapy.
    Miller CW; DeBlasi RF; Fisher SJ
    J Bone Joint Surg Am; 1976 Apr; 58(3):312-7. PubMed ID: 1063129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metastasis control by injection of blood lymphocytes cultured with neuraminidase-treated MT/W 449A rat mammary carcinoma.
    Watkins E; Anderson LL; Baralt OL; Heatley GJ
    J Biol Response Mod; 1984; 3(1):60-75. PubMed ID: 6707700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of erythrocytes sensitized with purified enterotoxin from Vibrio cholerae for the assay of antibody and antibody-forming cells.
    Kateley JR; Friedman H
    J Infect Dis; 1975 Feb; 131(2):144-8. PubMed ID: 1090686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced cures of spontaneous murine mammary tumors with surgery, combination chemotherapy, and immunotherapy.
    Martin DS; Hayworth PE; Fugmann RA
    Cancer Res; 1970 Mar; 30(3):709-16. PubMed ID: 5425293
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.
    Simmons RL; Rios A
    Natl Cancer Inst Monogr; 1973 Dec; 39():57-68. PubMed ID: 4595327
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunospecific regression of various syngeneic mouse tumors in response to neuraminidase-treated tumor cells.
    Rios A; Simmons RL
    J Natl Cancer Inst; 1973 Aug; 51(2):637-44. PubMed ID: 4765377
    [No Abstract]   [Full Text] [Related]  

  • 40. Phytomitogen and neuraminidase in the treatment of Ehrlich carcinoma in mice.
    Mobley JR; Graber CD; O'Brien PH; Gale GR; Neeley B
    Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):155-62. PubMed ID: 4438822
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.